71 related articles for article (PubMed ID: 18383817)
1. Inhibition of both mesothelioma cell growth and Cdk4 activity following treatment with a TATp16INK4a peptide.
Frizelle SP; Kratzke MG; Carreon RR; Engel SC; Youngquist L; Klein MA; Fourre L; Shekels LL; Kratzke RA
Anticancer Res; 2008; 28(1A):1-7. PubMed ID: 18383817
[TBL] [Abstract][Full Text] [Related]
2. Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression.
Frizelle SP; Grim J; Zhou J; Gupta P; Curiel DT; Geradts J; Kratzke RA
Oncogene; 1998 Jun; 16(24):3087-95. PubMed ID: 9671387
[TBL] [Abstract][Full Text] [Related]
3. A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.
Yang CT; You L; Lin YC; Lin CL; Mccormick F; Jablons DM
Anticancer Res; 2003; 23(1A):33-8. PubMed ID: 12680192
[TBL] [Abstract][Full Text] [Related]
4. Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.
Hosotani R; Miyamoto Y; Fujimoto K; Doi R; Otaka A; Fujii N; Imamura M
Clin Cancer Res; 2002 Apr; 8(4):1271-6. PubMed ID: 11948142
[TBL] [Abstract][Full Text] [Related]
5. A flavivirus protein M-derived peptide directly permeabilizes mitochondrial membranes, triggers cell death and reduces human tumor growth in nude mice.
Brabant M; Baux L; Casimir R; Briand JP; Chaloin O; Porceddu M; Buron N; Chauvier D; Lassalle M; Lecoeur H; Langonné A; Dupont S; Déas O; Brenner C; Rebouillat D; Muller S; Borgne-Sanchez A; Jacotot E
Apoptosis; 2009 Oct; 14(10):1190-203. PubMed ID: 19693674
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of established mesothelioma xenografts with recombinant p16INK4a adenovirus.
Frizelle SP; Rubins JB; Zhou JX; Curiel DT; Kratzke RA
Cancer Gene Ther; 2000 Nov; 7(11):1421-5. PubMed ID: 11129284
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients.
Usami N; Fukui T; Kondo M; Taniguchi T; Yokoyama T; Mori S; Yokoi K; Horio Y; Shimokata K; Sekido Y; Hida T
Cancer Sci; 2006 May; 97(5):387-94. PubMed ID: 16630136
[TBL] [Abstract][Full Text] [Related]
8. A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.
Zennami K; Yoshikawa K; Kondo E; Nakamura K; Upsilonamada Y; De Velasco MA; Tanaka M; Uemura H; Shimazui T; Akaza H; Saga S; Ueda R; Honda N
Oncol Rep; 2011 Aug; 26(2):327-33. PubMed ID: 21567093
[TBL] [Abstract][Full Text] [Related]
9. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
10. Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain.
Zhang XY; Dinh A; Cronin J; Li SC; Reiser J
J Neurochem; 2008 Feb; 104(4):1055-64. PubMed ID: 17986221
[TBL] [Abstract][Full Text] [Related]
11. Effect of transcription peptide inhibitors on HIV-1 replication.
Van Duyne R; Cardenas J; Easley R; Wu W; Kehn-Hall K; Klase Z; Mendez S; Zeng C; Chen H; Saifuddin M; Kashanchi F
Virology; 2008 Jul; 376(2):308-22. PubMed ID: 18455747
[TBL] [Abstract][Full Text] [Related]
12. A recombinant cell-permeable p53 fusion protein is selectively stabilized under hypoxia and inhibits tumor cell growth.
Yu Z; Wu J; Wu S; Jia P; Tong Y; Wu X; Wang Y
Cancer Lett; 2009 Jun; 279(1):101-7. PubMed ID: 19232460
[TBL] [Abstract][Full Text] [Related]
13. High dose of ascorbic acid induces cell death in mesothelioma cells.
Takemura Y; Satoh M; Satoh K; Hamada H; Sekido Y; Kubota S
Biochem Biophys Res Commun; 2010 Apr; 394(2):249-53. PubMed ID: 20171954
[TBL] [Abstract][Full Text] [Related]
14. A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells.
Lou H; Gao Y; Zhai M; Qi Y; Chen L; Lv H; Yu J; Li Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4633-7. PubMed ID: 18656352
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of novel chimeric peptides derived from cyclinD/CDK4 and the protein transduction domain 4.
Wang H; Chen X; Chen Y; Sun L; Li G; Zhai M; Zhai W; Kang Q; Gao Y; Qi Y
Amino Acids; 2013 Feb; 44(2):499-510. PubMed ID: 22802137
[TBL] [Abstract][Full Text] [Related]
16. [Cytotoxicity of chimera peptides incorporating sequences of cyclin kinases inhibitors].
Kharchenko VP; Kulinich VG; Lunin VG; Filiasova EI; Shishkin AM; Sergeenko OV; Riazanova EM; Voronina OL; Bozhenko VK
Vopr Onkol; 2007; 53(4):448-52. PubMed ID: 17969409
[TBL] [Abstract][Full Text] [Related]
17. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
Hseu YC; Chen SC; Chen HC; Liao JW; Yang HL
Food Chem Toxicol; 2008 Aug; 46(8):2680-8. PubMed ID: 18550246
[TBL] [Abstract][Full Text] [Related]
18. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
19. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
20. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
